Starling Oncology, Inc. Gain (Loss) on Extinguishment of Debt
Starling Oncology, Inc. (DFPH) reported Gain (Loss) on Extinguishment of Debt of $0 for the 12-month period ending 2023-12-31, per its 10-K filed 2024-03-28.
Discontinued › Expense Statement › Operating Expenses
us-gaap:GainsLossesOnExtinguishmentOfDebt · last filed 2024-03-28
- Starling Oncology, Inc. gain (loss) on extinguishment of debt for the quarter ending 2023-12-31 was $0.00.
- Starling Oncology, Inc. gain (loss) on extinguishment of debt for the quarter ending 2023-09-30 was $0.00.
- Starling Oncology, Inc. gain (loss) on extinguishment of debt for the quarter ending 2023-06-30 was $0.00.
- Starling Oncology, Inc. gain (loss) on extinguishment of debt for the quarter ending 2023-03-31 was $0.00, a 100.00% decline year-over-year.
- Starling Oncology, Inc. gain (loss) on extinguishment of debt for fiscal 2023 was $0.00, a 100.00% decline from fiscal 2022.
- Starling Oncology, Inc. gain (loss) on extinguishment of debt for fiscal 2022 was $183.00K, a 96.31% decline from fiscal 2021.
- Starling Oncology, Inc. gain (loss) on extinguishment of debt for fiscal 2021 was $4.96M.
- Starling Oncology, Inc. gain (loss) on extinguishment of debt for fiscal 2020 was $0.00.
| Period end | Gain (Loss) on Extinguishment of Debt 3 month | Gain (Loss) on Extinguishment of Debt 6 month | Gain (Loss) on Extinguishment of Debt 9 month | Gain (Loss) on Extinguishment of Debt 12 month |
|---|---|---|---|---|
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $0.00 derived: sum of 2 quarters · filed 2024-03-28 | $0.00 derived: sum of 3 quarters · filed 2024-03-28 | $0.00 10-K · filed 2024-03-28 |
| 2023-09-30 | $0.00 10-Q · filed 2023-11-08 | $0.00 derived: sum of 2 quarters · filed 2023-11-08 | $0.00 10-Q · filed 2023-11-08 | $0.00 derived: sum of 4 quarters · filed 2024-03-28 |
| 2023-06-30 | $0.00 10-Q · filed 2023-08-09 | $0.00 10-Q · filed 2023-08-09 | $0.00 derived: sum of 3 quarters · filed 2024-03-28 | $0.00 derived: sum of 4 quarters · filed 2024-03-28 |
| 2023-03-31 | $0.00 10-Q · filed 2023-05-10 | $0.00 derived: sum of 2 quarters · filed 2024-03-28 | $0.00 derived: sum of 3 quarters · filed 2024-03-28 | $0.00 derived: sum of 4 quarters · filed 2024-03-28 |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $0.00 derived: sum of 2 quarters · filed 2024-03-28 | $0.00 derived: sum of 3 quarters · filed 2024-03-28 | $183.00K 10-K · filed 2024-03-28 |
| 2022-09-30 | $0.00 10-Q · filed 2023-11-08 | $0.00 derived: sum of 2 quarters · filed 2023-11-08 | $183.00K 10-Q · filed 2023-11-08 | -$46.00K derived: sum of 4 quarters · filed 2023-11-08 |
| 2022-06-30 | $0.00 10-Q · filed 2023-08-09 | $183.00K 10-Q · filed 2023-08-09 | -$46.00K derived: sum of 3 quarters · filed 2023-08-09 | -$46.00K derived: sum of 4 quarters · filed 2023-08-09 |
| 2022-03-31 | $183.00K 10-Q · filed 2023-05-10 | -$46.00K derived: sum of 2 quarters · filed 2023-05-10 | -$46.00K derived: sum of 3 quarters · filed 2023-05-10 | $5.14M derived: sum of 4 quarters · filed 2023-05-10 |
| 2021-12-31 | -$229.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | -$229.00K derived: sum of 2 quarters · filed 2023-03-16 | $4.96M derived: sum of 3 quarters · filed 2023-03-16 | $4.96M 10-K · filed 2023-03-16 |
| 2021-09-30 | $0.00 10-Q · filed 2022-11-09 | $5.19M derived: sum of 2 quarters · filed 2022-11-09 | $5.19M 10-Q · filed 2022-11-09 | |
| 2021-06-30 | $5.19M 10-Q · filed 2022-08-09 | $5.19M 10-Q · filed 2022-08-09 | ||
| 2021-03-31 | $0.00 10-Q · filed 2022-05-10 | |||
| 2020-12-31 | $0.00 10-K · filed 2022-03-11 |